izpis_h1_title_alt

N-hydroxy-N-propargylamide derivatives of ferulic acid : inhibitors of cholinesterases and monoamine oxidases
ID Bautista-Aguilera, Oscar M. (Author), ID Alonso, José M. (Author), ID Catto, Marco (Author), ID Iriepa, Isabel (Author), ID Knez, Damijan (Author), ID Gobec, Stanislav (Author), ID Marco-Contelles, José (Author)

.pdfPDF - Presentation file, Download (792,16 KB)
MD5: 43DB8F68B71C521F26574F9486E9F3A9
URLURL - Source URL, Visit https://www.mdpi.com/1420-3049/27/21/7437 This link opens in a new window

Abstract
Alzheimer’s disease (AD) is a complex disorder characterized by impaired neurotransmission in cholinergic and monoaminergic neurons, which, in combination with the accumulation of misfolded proteins and increased oxidative stress, leads to the typical features of the disease at the biomolecular level. Given the limited therapeutic success of approved drugs, it is imperative to explore rationally supported therapeutic approaches to combat this disease. The search for novel scaffolds that bind to different receptors and inhibit AD disease-related enzymes could lead to new therapeutic solutions. Here, we describe N-hydroxy-N-propargylamide hybrids 1–6, which were designed by combining the structures of Contilisant—a multifunctional anti-AD ligand—and ferulic acid, a natural antioxidant with various other biological activities. Among the synthesized compounds, we identified compound 4 as a micromolar inhibitor of hAChE with a potent radical-scavenging capacity comparable to resveratrol and Trolox. In addition, compound 4 chelated copper(II) ions associated with amyloid β pathology, mitochondrial dysfunction, and oxidative stress. The promising in vitro activity combined with favorable drug-like properties and predicted blood‒brain barrier permeability make compound 4 a multifunctional ligand that merits further studies at the biochemical and cellular levels.

Language:English
Keywords:cholinesterases, ferulic acid, molecular modelling, monoamine oxidase, radical-scavenger, antioxidant
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:18 str.
Numbering:Vol. 27, iss. 21, art. 7437
PID:20.500.12556/RUL-142354 This link opens in a new window
UDC:616.894
ISSN on article:1420-3049
DOI:10.3390/molecules27217437 This link opens in a new window
COBISS.SI-ID:127684867 This link opens in a new window
Publication date in RUL:02.11.2022
Views:355
Downloads:62
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:holinesteraze, ferulna kislina, molekularno modeliranje, monoaminooksidaza, lovilec radikalov, antioksidant

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208-2015
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back